For help on how to get the results you want, see our search tips.
59 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Refused Remove Refused filter
-
List item
Human medicine European public assessment report (EPAR): Nerventra
laquinimod, Multiple Sclerosis
Date of refusal: 19/08/2014, Refused, Last updated: 01/09/2014 -
List item
Human medicine European public assessment report (EPAR): Masican
masitinib, Gastrointestinal Stromal Tumors
Date of refusal: 04/07/2014,
, Refused, Last updated: 22/11/2013
-
List item
Human medicine European public assessment report (EPAR): Kynamro
mipomersen sodium, Hypercholesterolemia
Date of refusal: 29/05/2013, Refused, Last updated: 17/06/2013 -
List item
Human medicine European public assessment report (EPAR): Qsiva
phentermine, topiramate, Obesity
Date of refusal: 14/05/2013, Refused, Last updated: 13/06/2013 -
List item
Human medicine European public assessment report (EPAR): Labazenit
Budesonide, salmeterol, Asthma
Date of refusal: 06/09/2013, Refused, Last updated: 22/03/2013 -
List item
Human medicine European public assessment report (EPAR): Istodax
romidepsin, Lymphoma, Non-Hodgkin
Date of refusal: 12/02/2013,, Refused, Last updated: 14/03/2013
-
List item
Human medicine European public assessment report (EPAR): Balaxur
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Acrescent
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Elelyso
Taliglucerase alfa, Gaucher Disease
Date of refusal: 25/10/2012,, Refused, Last updated: 23/11/2012
-
List item
Human medicine European public assessment report (EPAR): Folotyn
Pralatrexate, Lymphoma, T-Cell
Date of refusal: 21/06/2012,, Refused, Last updated: 11/07/2012
-
List item
Human medicine European public assessment report (EPAR): Sumatriptan Galpharm
sumatriptan succinate, Migraine Disorders
Date of refusal: 09/02/2012,
, Refused, Last updated: 16/02/2012
-
List item
Human medicine European public assessment report (EPAR): Zeftera (previously Zevtera)
ceftobiprole medocaril, Skin Diseases, Infectious; Soft Tissue Infections
Date of refusal: 16/09/2010, Refused, Last updated: 22/09/2010 -
List item
Human medicine European public assessment report (EPAR): Impulsor
milnacipran, Fibromyalgia
Date of refusal: 08/04/2010, Refused, Last updated: 26/04/2010 -
List item
Human medicine European public assessment report (EPAR): Milnacipran Pierre Fabre Medicament
milnacipran, Fibromyalgia
Date of refusal: 08/04/2010, Refused, Last updated: 26/04/2010 -
List item
Human medicine European public assessment report (EPAR): Sovrima
idebenone, Friedreich Ataxia
Date of refusal: 27/04/2009,, Refused, Last updated: 31/12/2009
-
List item
Human medicine European public assessment report (EPAR): Zelnorm
tegaserod, Irritable Bowel Syndrome
Date of refusal: 19/05/2006, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Rhucin
recombinant human C1 inhibitor, Angioedema
Date of refusal: 22/05/2008, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Genasense
oblimersen, Melanoma
Date of refusal: 15/10/2007, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Gemesis
becaplermin, Guided Tissue Regeneration, Periodontal
Date of refusal: 29/01/2010, Refused, Last updated: 20/11/2009 -
List item
Human medicine European public assessment report (EPAR): Cimzia
Certolizumab pegol, Crohn Disease
Date of refusal: 21/05/2008, Refused, Last updated: 20/03/2008 -
List item
Human medicine European public assessment report (EPAR): Natalizumab Elan Pharma
natalizumab, Crohn Disease
Date of refusal: 11/01/2008, Refused, Last updated: 25/01/2008 -
List item
Human medicine European public assessment report (EPAR): Mylotarg
gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of refusal: 14/04/2008,, Refused, Last updated: 24/01/2008
-
List item
Human medicine European public assessment report (EPAR): Mycograb
recombinant human monoclonal antibody to hsp, Candidiasis
Date of refusal: 22/05/2007, Refused, Last updated: 21/03/2007 -
List item
Veterinary medicine European public assessment report (EPAR): Veraflox
pradofloxacin, Dogs
Date of refusal: 11/12/2006, Refused, Last updated: 24/01/2007 -
List item
Human medicine European public assessment report (EPAR): Thymanax
Agomelatine, Depressive Disorder, Major
Date of refusal: 16/01/2007, Refused, Last updated: 27/07/2006